Secondary outcomes
depression
All other symptoms were less prevalent in patients taking fluvoxamine except for poor concentration (19% in fluvoxamine vs. 16.3% in placebo), Although none were significant. Most considerable one was depression (2.4% in fluvoxamine vs. 16.3% in placebo, 